FGFR3 and urinary bladder neoplasm: To this end, we considered the case of activating mutations of fibroblast growth factor receptor 3 (FGFR3) and of the oncogene PI3K, one of the co-occurrent genetic perturbations observed in bladder tumors (see Remy et al., 2015).